These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9229168)

  • 41. Neonatal jaundice.
    McKiernan P
    Clin Res Hepatol Gastroenterol; 2012 Jun; 36(3):253-6. PubMed ID: 22609294
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases.
    Trauner M; Graziadei IW
    Aliment Pharmacol Ther; 1999 Aug; 13(8):979-96. PubMed ID: 10468672
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Treatment of primary biliary cirrhosis].
    Szalay F
    Orv Hetil; 2003 Sep; 144(36):1787-8. PubMed ID: 14579676
    [No Abstract]   [Full Text] [Related]  

  • 44. TPN cholestasis in premature infants: the role of parenteral nutrition solutions.
    Sheard NF; Kleinman RE
    Pediatr Ann; 1987 Mar; 16(3):243, 246, 248 passim. PubMed ID: 3108841
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Abnormal liver functions as a result of total parenteral nutrition in a patient with short-bowel syndrome.
    Burstyne M; Jensen GL
    Nutrition; 2000; 16(11-12):1090-2. PubMed ID: 11118832
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ursodeoxycholic acid in the treatment of cholestasis and hyperbilirubinemia in pediatric intensive care unit patients.
    George R; Stevens A; Berkenbosch JW; Turpin J; Tobias J
    South Med J; 2002 Nov; 95(11):1276-9. PubMed ID: 12539993
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Urinary 1 beta-hydroxyursodeoxycholic acid during ursodeoxycholic acid therapy.
    Yamakawa R; Kimura A; Aoki K; Suzuki M; Mahara R; Tohma M
    J Gastroenterol; 1996 Dec; 31(6):917-8. PubMed ID: 9027662
    [No Abstract]   [Full Text] [Related]  

  • 48. Ursodeoxycholic acid for treatment of cholestasis in patients with hepatic amyloidosis.
    Faust D; Akoglu B; Ristic G; Milovic V
    Vojnosanit Pregl; 2009 Jun; 66(6):482-6. PubMed ID: 19583148
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Medical treatment of chronic cholestasis: ursodeoxycholic acid].
    Linares Rodríguez A
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():24-38. PubMed ID: 11968340
    [No Abstract]   [Full Text] [Related]  

  • 50. Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective study.
    Stiehl A; Rudolph G; Sauer P; Benz C; Stremmel W; Walker S; Theilmann L
    J Hepatol; 1997 Mar; 26(3):560-6. PubMed ID: 9075663
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effect of the administration of cholecystokinin on the cholestasis associated with total parenteral nutrition in experimental short bowel].
    García-Urkia N; Asensio AB; Cano A; Samprón N; García-Arenzana JM; Bachiller P; Aldazabal P; Eizaguirre I
    Cir Pediatr; 2007 Jul; 20(3):180-2. PubMed ID: 18018748
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ursodeoxycholic acid therapy in children with cholestatic liver disease.
    Dinler G; Koçak N; Yüce A; Gürakan F; Ozen H
    Turk J Pediatr; 1999; 41(1):91-8. PubMed ID: 10770681
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Delayed postnatal presentation of biliary atresia in 2 premature neonates.
    Mourier O; Franchi-Abella S; Ackermann O; Branchereau S; Gonzales E; Bernard O; Jacquemin E
    J Pediatr Gastroenterol Nutr; 2011 Apr; 52(4):489-91. PubMed ID: 21407106
    [No Abstract]   [Full Text] [Related]  

  • 54. [Cholestasis associated with total parenteral feeding in premature infants].
    Teeuw AH; de Leeuw R; Taminiau JA
    Tijdschr Kindergeneeskd; 1993 Aug; 61(4):147-51. PubMed ID: 8122226
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Mechanism of action of ursodeoxycholic acid in cholestatic liver diseases].
    Lévy S; Capron JP; Erlinger S
    Gastroenterol Clin Biol; 1996; 20(6-7):549-59. PubMed ID: 8881567
    [No Abstract]   [Full Text] [Related]  

  • 56. The value of routine laboratory screening in the neonatal intensive care unit.
    Kazmi SH; Caprio M; Boolchandani H; Mally P; Bailey S; Desai P
    J Neonatal Perinatal Med; 2020; 13(2):247-251. PubMed ID: 31796688
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is ursodeoxycholic acid effective for intrahepatic cholestasis of pregnancy?
    Sepúlveda Marín S; Contreras Maragaño V; Vera C
    Medwave; 2016 Jan; 16 Suppl 1():e6361. PubMed ID: 26817509
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Cholestatic acute hepatitis induced by amoxycillin-clavulanic acid combination. Role of ursodeoxycholic acid in drug-induced cholestasis].
    Barrio J; Castiella A; Lobo C; Indart A; López P; García-Bengoechea M; Cosme A; Arenas JI
    Rev Esp Enferm Dig; 1998 Jul; 90(7):523-6. PubMed ID: 9741209
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment.
    Stiehl A; Rudolph G; Sauer P; Theilmann L
    J Hepatol; 1995 Sep; 23(3):283-9. PubMed ID: 8550992
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatic secretory obstruction with total parenteral nutrition in the infant.
    Touloukian RJ; Seashore JH
    J Pediatr Surg; 1975 Jun; 10(3):353-60. PubMed ID: 806674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.